China Chromium-Capsule Scandal Focus Turns To Provincial Regulators
This article was originally published in PharmAsia News
Executive Summary
China’s scandal involving contaminated drug capsules is leading to concerns of laxity by regulatory authorities as well as law enforcement officials who may have been partly responsible.